The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 25, 2021

Filed:

Nov. 30, 2018
Applicant:

4d Pharma Research Limited, Aberdeen, GB;

Inventor:

Denise Kelly, Aberdeen, GB;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/747 (2015.01); A23L 33/135 (2016.01); C12R 1/225 (2006.01); C12R 1/23 (2006.01); C12R 1/25 (2006.01); C12N 1/20 (2006.01); A23K 10/18 (2016.01);
U.S. Cl.
CPC ...
A61K 35/747 (2013.01); A23K 10/18 (2016.05); A23L 33/135 (2016.08); C12N 1/20 (2013.01); C12R 1/225 (2013.01); C12R 1/23 (2013.01); C12R 1/25 (2013.01); A23V 2002/00 (2013.01); Y02A 50/30 (2018.01);
Abstract

A first aspect of the invention relates to a porcine lactic acid bacterial strain, wherein said bacterial strain is characterised by one or more of the following characteristics: (i) the ability to exhibit antimicrobial activity against; (ii) the ability to exhibit antimicrobial activity against; (iii) the ability to suppress inflammation in IPEC cells induced by 12-0-tetradecaboylphorbol-13-acetate (PMA); (iv) the ability to block the attachment or invasion of IPEC cells by; (v) the ability to block the attachment or invasion of IPEC cells by; (vi) the absence of antibiotic resistance to one or more antibiotics selected from the following: ampicillin; cefotaxime; chloramphenicol; erythromycin; gentamicin; tetracycline; vancomycin; metronizadole; nalidixic acid; and kanamycin; and (vii) the ability to exhibit heat stability when subjected to three cycles of heating, each cycle comprising heating at a temperature of 70° C. for a period of 15 minutes. Further aspects of the invention relate to compositions comprising said bacterial strains, and therapeutic uses of said bacterial strains.


Find Patent Forward Citations

Loading…